Concurrent Speaker :
Kevin C. Halling, MD, PhD
Co-Director of the Clinical Molecular Genetics Laboratory / Consultant, Divisions of Laboratory Genetics and Clinical Genomics
Kevin Halling, MD, PhD is a molecular pathologist and an Associate Professor in Mayo Clinic's Department of Laboratory Medicine in Rochester, MN. He directs the Clinical Molecular Genetics Laboratory which performs molecular oncology and hereditary disorder testing. He is also the Vice Chair for Research and Development for the department. He completed a PhD in Biochemistry and an MD at the University of Kansas. He did an Anatomic and Clinical pathology residency and Clinical Molecular Genetics fellowship at the Mayo Clinic. His primary area of interest is in the development of genetic tests that can be used for the diagnosis and treatment of sporadic and hereditary cancer. He and his team are currently working on the development of a clinical RNA Seq assay that can be used to detect gene fusions in patients with various types of malignancies. Dr. Halling has published over 100 papers that mostly relate to genetic testing of cancer.
Wednesday, September 12
1:30 PM – 3:00 PM